Out of the frying-pan into the fire: a supraventricular tachycardia triggering a ventricular tachycardia in a patient with ischaemic cardiomyopathy and an implantable-cardioverter defibrillator

2010 ◽  
Vol 31 (19) ◽  
pp. 2368-2368 ◽  
Author(s):  
A. Sorgente ◽  
C. de Asmundis ◽  
G. B. Chierchia ◽  
P. Brugada
2018 ◽  
Vol 28 (6) ◽  
pp. 890-893
Author(s):  
Hisaaki Komaki ◽  
Takashi Nakashima ◽  
Shinya Minatoguchi

AbstractIn some patients with Kawasaki disease, a prior myocardial infarction causes ventricular tachycardia in the chronic post-myocardial infarction phase. We report the case of a 41-year-old man with symptomatic and haemodynamically unstable ventricular tachycardia in whom substrate ablation was performed for the ventricular tachycardia before insertion of an implantable cardioverter-defibrillator.


2014 ◽  
Vol 41 (3) ◽  
pp. 329-331 ◽  
Author(s):  
Fayaz Ahmad Hakim ◽  
Anil Pandit ◽  
Farouk Mookadam ◽  
Sylvia Mamby

Benign cardiac fibroma is rarely reported in adults. Its clinical symptoms are related to outflow obstruction or dysrhythmias. We present the case of a 70-year-old woman who had a syncopal episode from ventricular tachycardia caused by cardiac fibroma. Because of unfavorable tumor anatomy, the patient was not a candidate for surgical excision, and she declined orthotopic heart transplantation. To prevent sudden cardiac death, we placed an implantable cardioverter-defibrillator, and the patient remained well throughout the 2-year follow-up period. To our knowledge, this is the first report of implantable cardioverter-defibrillator therapy to treat an adult patient's unresectable cardiac fibroma.


2020 ◽  
Vol 9 (5) ◽  
pp. 375-385
Author(s):  
Michael E Field ◽  
Laura Goldstein ◽  
Stephanie Hsiao Yu Lee ◽  
Iftekhar Kalsekar ◽  
Paul Coplan ◽  
...  

Aim: To compare outcomes among patients with implantable cardioverter defibrillator/cardiac resynchronization therapy-defibrillator undergoing outpatient ventricular tachycardia (VT) catheter ablation using intracardiac echocardiography (ICE) versus no ICE. Patients & methods: Patients were classified into ICE (n = 1143)/non-ICE (n = 1677) groups based on ICE procedure codes. Patients in each group were propensity matched on study covariates. Survival analyses were used to assess outcomes. To examine residual confounding, falsification outcomes were evaluated. Results: ICE patients had a 24% lower risk of all-cause readmissions, 24% lower risk of cardiovascular-related and 20% lower risk of VT-related readmissions compared with non-ICE patients. Falsification analyses for ICE use association were nonsignificant. Conclusion: Patients with implantable cardioverter defibrillator/cardiac resynchronization therapy-defibrillator undergoing VT ablation with ICE use had significantly lower likelihood of VT-related readmission.


Sign in / Sign up

Export Citation Format

Share Document